Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
CDK2 and CDK9 respectively
000nM) against a panel of >120 unrelated kinases
2-dihydroquinoline-6-sulfonamido)-N-[(thiophen-2-yl)methyl]acetamide
with IC50 of
Acta Crystallogr C
IRAK4-IN-7 - CAS# 1801343-74-7 Catalog No.:M17442-C CDK2 and CDK9 respectivelyIRAK4 IN 7 is a selective, potent and orally active interleukin 1 receptor associated kinase 4 (IRAK4) inhibitor, extracted from patent WO2015104688 (example 1). IRAK4 IN 7 has the potential for cancer and inflammatory diseases treatment. Product information CAS Number: 1801343 74 7 Molecular Weight: 417. 42 Formula: C21H19N7O3 Chemical Name: 6' amino N (2 morpholinooxazolo[4, 5 b]pyridin 6 yl) [2, 3' bipyridine] 6 carboxamide Smiles:
US$ 162.00
US$ 202.00
US$ 143.50